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Background: Adult rat hypothalamo-pituitary axis and choroid plexus are rich in basic fibroblast growth factor
(FGF2) which likely has a role in fluid homeostasis. Towards this end, we characterized the distribution and
modulation of FGF2 in the human and rat central nervous system. To ascertain a functional link between arginine
vasopressin (AVP) and FGF2, a rat model of chronic dehydration was used to test the hypothesis that FGF2
expression, like that of AVP, is altered by perturbed fluid balance.
Methods: Immunohistochemistry and confocal microscopy were used to examine the distribution of FGF2 and
AVP neuropeptides in the normal human brain. In order to assess effects of chronic dehydration, Sprague-Dawley
rats were water deprived for 3 days. AVP neuropeptide expression and changes in FGF2 distribution in the brain,
neural lobe of the pituitary and kidney were assessed by immunohistochemistry, and western blotting (FGF2
isoforms).
Results: In human hypothalamus, FGF2 and AVP were co-localized in the cytoplasm of supraoptic and
paraventricular magnocellular neurons and axonal processes. Immunoreactive FGF2 was associated with small
granular structures distributed throughout neuronal cytoplasm. Neurohypophysial FGF2 immunostaining was found
in axonal processes, pituicytes and Herring bodies. Following chronic dehydration in rats, there was substantially-
enhanced FGF2 staining in basement membranes underlying blood vessels, pituicytes and other glia. This
accompanied remodeling of extracellular matrix. Western blot data revealed that dehydration increased expression
of the hypothalamic FGF2 isoforms of ca. 18, 23 and 24 kDa. In lateral ventricle choroid plexus of dehydrated rats,
FGF2 expression was augmented in the epithelium (Ab773 as immunomarker) but reduced interstitially (Ab106
immunostaining).
Conclusions: Dehydration altered FGF2 expression patterns in AVP-containing magnocellular neurons and
neurohypophysis, as well as in choroid plexus epithelium. This supports the involvement of centrally-synthesized
FGF2, putatively coupled to that of AVP, in homeostatic mechanisms that regulate fluid balance.
Background
Fluid homeostasis in the brain and periphery is
mediated by peptides synthesized in extrahypothalamic
and hypothalamic regions, respectively, of the CNS. In
regard to brain water balance, the arginine vasopressin
(AVP) expressed in choroid plexus epithelium
(parenchymal cells) exerts an autocrine effect on cere-
brospinal fluid (CSF) secretion [1-3]. CSF derived from
choroid plexus is the primary determinant of brain
extracellular fluid volume and composition [4]. Such
CSF formation is controlled partly by vasopressinergic
(V1) inhibitory effects on choroidal blood flow [5-7] and
ion transport [8]. Choroid epithelial ultrastructure is
also transformed by AVP, again suggesting a peptide-
induced reduction in fluid movement at CNS transport
interfaces [9]. On the other hand, peripheral water
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delivered to the neurohypophysis eventually to adjust
renal ion transport and thus water balance.
Although basic FGF (FGF2) and its receptors [10-12]
are known to be expressed in choroid plexus [13,14],
their multiple functions await further elucidation.
Growth factors, like neuropeptides, exert acute actions
on blood flow and transport in various epithelia. For
example, FGF2 infusion alters tissue perfusion by chan-
ging vessel diameter [15]. Moreover, exogenously admi-
nistered FGF2 and AVP reduce CSF formation rate
[7,16] and induce the dark choroid epithelial cells impli-
cated in neuroendocrine regulation of water balance
[8,9,17]. Because FGF high affinity receptors (FGFR) co-
localize with AVP in parenchymal cells of choroid
plexus [18], it is tempting to postulate a functional sym-
metry, perhaps coupling, that links FGF2, AVP and CNS
water balance.
FGF2 and AVP are also expressed in the hypothala-
mus and hypophysis [14,19]. But while stimuli that acti-
vate magnocellular neurons in the paraventricular
(PVN) and supraoptic nucleus (SON) enhance secretion
of AVP into blood and CSF [20], FGF2 function in the
hypothalamo-hypophyseal system is less understood.
Still, the prominent distribution of FGF2 and its recep-
tors within SON, PVN, median eminence and neurohy-
pophysis, as well as choroid plexus, implies a role for
FGF2 in ion/water homeostasis [14,18,19,21-23]. To this
end, the more recent observations intimating a func-
tional link between FGF2 secretion and the ion-trans-
porting Na
+-K
+ ATPase [24,25] strongly supports
involvement of FGF2 in water homeostasis. FGF2 and
AVP co-localize in epithelial cells of the choroid plexus.
Therefore we postulated that these peptides also occur
together in certain neuroendocrine cells of the hypotha-
lamus, another region involved in fluid homeostasis.
The aim of these studies was to characterize the distri-
bution and modulation of FGF2 in the human and rat
CNS. In the findings presented here, we analyzed the
distribution of FGF2 and AVP immunoreactivity in the
SON, PVN, and neurohypophysis in human specimens
obtained at autopsy. Confocal microscopy clearly
revealed co-localization of FGF2 and AVP in SON as
well as PVN magnocellular neurons. Moreover, given
the increased expression of FGF2 in hypothalamus and
choroid plexus now being reported in a rat model of
disrupted water balance, our findings fit the model that




All human tissue samples were obtained with the
approval of the Local Research and Ethics Committee.
Female and male brain specimens (n = 5) were obtained
within 4-18 h of death, and subjected to neuropatholo-
gic examination to exclude CNS abnormalities. The
hypothalamus was dissected en-bloc and fixed in 4% for-
maldehyde. Specimens were immersed in 30% sucrose
and snap frozen in liquid N2 for storage at -80°C. Coro-
nal sections were cut on a freezing microtome at 8 μm
and mounted on positive-charged slides. Fig. 1 illustrates
the anatomical regions used in the current studies and
from which representative photographs were obtained.
Immunohistochemical procedures used specific poly-
clonal antibodies raised against human FGF2 (Ab773)
and AVP (Immunostar, Hudson, WI, USA). This anti-
body has been shown not to cross react with oxytocin.
Double fluorescence labeling was performed sequen-
tially. Briefly, 8-μm slide-mounted sections were washed
in 0.05 M TBS buffer pH 7.6, then pre-treated with 3%
H2O2 in methanol, 1% milk, 1.6% ammonium acetate,
0.1% normal goat serum (Jackson ImmunoResearch,
West Grove, PA, USA) in 0.05 M TBS and 0.1% Triton
X-100 before incubation with the rabbit anti-FGF2 anti-
body (Ab773, 1/1000) for 24 h at 4°C. Sections were
rinsed thoroughly with 0.05M TBS pH7.6 containing
0.2% Triton and then incubated with rhodamine-tagged
goat anti rabbit (Jackson ImmunoResearch) for 3 h at
4°C. Slides were rinsed thoroughly with 0.05M TBS
pH7.6 containing 0.2% Triton, incubated with rabbit
anti-vasopressin antibody (1/1000) for 24 h at 4°C,
rinsed and incubated with fluorescein-tagged goat anti
rabbit (Jackson ImmunoResearch) for 3 h at 4°C. Slides
were finally rinsed in TBS buffer, followed by distilled
water, coverslipped and stored in the dark.
The specificity of the antibodies used for double stain-
ing was assessed by the following controls. First, to test
for cross reaction of the primary antibodies, sections
were adsorbed with excess purified human FGF2 in
diluted antiserum. FGF2 immunoreactivity disappeared
and AVP immunoreactivity was unchanged, indicating
t h a tt h eF G F 2a n t i b o d yd i dn o tr e c o g n i z eA V P( n o t
shown). Then the specificityo ft h es e c o n d a r yl i n k i n g
antibodies was tested by omitting primary antibodies in
the respective experiments. Such tests indicated that
each secondary antibody did not cross-react with either
the primary or the linking antibody that visualized the
other protein. Antibody specificity was also confirmed
from differential distribution of FGF2 and AVP staining
in various regions of brain (not shown).
Fluorescent preparations were examined by a Nikon
Confocal Microscope and a krypton/argon laser with a
580-nm long-pass dichroic filter. Tissues were excited at
wavelengths of 488 or 568 nm and images obtained with
barrier filters of 515 or 590nm. Images were collected as
single pairs or sets of sequential images. Pixel dimen-
sions (x, y) were 0.56 (20x) and 0.09 μm (100x, oil). The
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was larger, i.e. spaced farther apart to generate a series
over a larger distance. Images were scanned on the two
channels (red, LRSC and green, FITC) and merged to
produce a single profile. In this mode, all regions exhi-
biting co-localization of red and green emitter produced
yellow fluorescence. Relationships between immunoreac-
tive FGF2- and AVP-containing elements were visua-
lized in 2 and 3 dimensions using InterVision software
(Thermo Noran, Inc., Madison, WI, USA).
Rat Studies
All animal procedures were carried out with strict
adherence to guidelines in the NIH Guide for the Care
and Use of Laboratory Animals and with the approval of
the Local Research and Ethics Committee. Adult male
Sprague-Dawley rats (200 to 250g) were housed under
normal laboratory conditions (12-h light/dark cycles)
with food and water ad libitum f o ro n ew e e kp r i o rt o
experimentation. Rats were divided into two groups of 8
rats. In the water-deprivation group, no water was pro-
vided for 72h. Control rats received tap water. Both
groups accessed food ad libitum. Prior to sacrifice, ani-
mals were anesthetized by pentobarbitone overdose (125
mg/kg, i.p), perfused transcardially with physiological
saline followed by 4% formaldehyde in PBS. Brains were
extricated, post-fixed overnight, dehydrated and
embedded in paraffin.
Figure 1 Diagram depicting sampling sites in human brain: Shaded areas are regions photographed*: supraoptic nucleus (SON, son),
paraventricular nucleus (PVN, pvn) and neurohypophysis (nh). Adjacent sites include third ventricle (V3) and optic chiasm (OC). Choroid plexus
tissue is attached to the roof of the 3rd ventricle and on the floor of the lateral ventricle (not shown) that is located above the fornix (Fx). IC,
intermediate capsule; gp, globus pallidus; pu, putamen; AC, anterior commissure; vp, ventral pallidum; a, amygdala.
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rabbit polyclonal antibodies were used: (1) Ab773, an
antibody raised against amino acids 1-24 of bovine
FGF2 (1-146) with high affinity for extracellular FGF2
[26]. This antibody has broad cross-reactivity with FGF2
from several animal species; and (2) Ab106, an antibody
raised against amino acids 1-23 of rat FGF2 (1-146).
Ab106 recognizes rat FGF2 and has high affinity for
intracellular FGF2. A purified IgG antibody fraction was
prepared by passage over a protein A sepharose column
(Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Staining specificity was verified by immunostaining sec-
tions with the antibody in the presence of the antigenic
peptide or the eluant from the affinity column used to
purify the antibody. For the rat studies, vasopressin
immunoreactivity was demonstrated using a rabbit poly-
clonal antibody against AVP (Chemicon, Millipore Bill-
erica, MA, USA). This antibody recognizes vasopressin
and has < 1% cross-reactivity with oxytocin. Immunos-
taining was done with a modified avidin-biotin complex
technique described previously [19]. Endogenous peroxi-
dase was quenched by treating the 8-μm section with
0.5% H2O2 in PBS for 30 min. Tissue sections were
rinsed and incubated in 1.5% normal goat serum (Jack-
son ImmunoResearch), and then incubated at 4°C over-
night with Ab773 or Ab106 diluted in PBS containing
0.3% triton and 5% bovine serum albumin (Jackson
ImmunoResearch). Sections were then incubated with
goat biotinylated anti-rabbit antibody (Vector, Burlin-
game, CA, USA), followed by an avidin-biotin-peroxi-
dase complex (Vector). Finally, the sections were treated
with 0.5% diaminobenzidin e( D A B ,S i g m a ,S t .L o u i s ,
MO, USA) in PBS containing 0.01% H2O2.D A B - t r e a t e d
sections were counterstained with hematoxylin, rinsed,
dehydrated, and protected with coverslips. Alternatively,
tissue sections were incubated for 30 min with a fluores-
cein-labeled donkey anti-rabbit antibody (Jackson
ImmunoResearch), rinsed, protected with coverslips and
observed under an epifluorescence microscope.
Immunoblotting for FGF2 was performed on rat
hypothalamus (anterior, medial, dorsal and posterior), as
well as on heart (atria plus ventricles) and kidney (cor-
tex plus medulla), in order to compare levels of FGF2
protein expression in neural vs. non-neural tissues. Wes-
tern blot procedures [25] were performed with some
modifications: the hypothalami and other tissues were
homogenized in iced extraction buffer [10 mM Tris pH
7.4, containing 2M NaCl, 1 mM EGTA, 1 mM EDTA,
0.4 mM PMSF (Calbiochem, EMD Chemicals, Gibbs-
t o w n ,N J ,U S A ) ,5μg/ml pepstatin A (MP Biomedicals,
Irvine, CA, USA), 5 μg/ml aprotinin (Sigma), and 5 μg/
ml leupeptin (MP Biomedicals)], centrifuged at 14,000
rpm at 4°C and the pellet re-suspended in 10 mM Tris,
pH 7.4. Protein concentrations were determined by the
BCA protein assay reagent (Thermo Scientific, Rockford,
IL, USA). Equal amounts of protein (500 μg) from each
sample were incubated for 16 h at 4°C with pre-washed
heparin-Sepharose CL-6B (Pharmacia Sweden). Beads
were then washed with 10 mM Tris buffer pH 7.4 and
re-suspended in 50 μl of Laemli’s buffer (Sigma). Sam-
ples were heated at 100°C for 3 min and the supernatant
electrophoresed on 18% SDS-PAGE and electroblotted
onto nitrocellulose. The membrane was incubated in
10 mM Tris buffer pH 7.4 containing 5% non-fat milk
(NFM/TBS) for 48 h at 4°C, and then incubated with
rabbit anti-rat FGF2 (Ab106) diluted in NFM/TBS for
1h at room temperature, rinsed and incubated with
125I-
Protein A (2 μC/10 ml) (GE Healthcare, Amersham, Pis-
cataway, NJ, USA) in NFM/TBS. Signals were detected
by autoradiography. Immunoblotting was repeated three
times with different preparations of tissue extracts.
Results
FGF2 and AVP immunoreactivity in human
paraventricular nucleus
Immunoreactive FGF2 and AVP were co-localized in the
PVN of three human hypothalami. FGF2 immunoreac-
tivity was found within the magnocellular neurons and
their processes (Fig. 2A, arrowheads) which extended to
the median eminence and posterior pituitary gland (not
shown). FGF2 immunoreactivity was also clearly evident
in endothelial cells within cerebral vessels (Fig. 2A,
arrows) and astrocytes identified morphologically. Single
labeled anti-AVP (FITC-stained) was detected within
the neuronal perikarya and processes (Fig. 2B, arrow-
heads) of the neurons. AVP immunoreactivity was
homogeneously distributed in the neuronal cytoplasm
and processes. Neuronal nuclei were devoid of staining.
We demonstrated co-localized FGF2 and AVP immu-
noreactivity by the appearance of yellow fluorescence
when the images of FITC-stained anti-AVP and LRSC-
stained anti-FGF2 immunoreactivities were merged (Fig.
2C). Yellow fluorescence was seen in nearly all magno-
cellular neurons. Juxtaposed neuronal processes
appeared as small yellow dots on the surface of cerebral
vessels. Some of the red LRSC-stained structures, which
lacked yellow fluorescence, were astrocytes and their
processes.
FGF2 and AVP immunoreactivity in human supraoptic
nucleus
In the human SON, immunoreactive FGF2 was
observed as small granule-like structures located pri-
marily in the apical portion of the neuronal perikaryon,
an area immediately above the nucleus of the neuron
in which the Golgi apparatus and endoplasmic reticu-
lum are located (Fig. 3A). In contrast, immunoreactive
AVP was more homogeneously distributed throughout
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Page 4 of 11Figure 2 Co-localization of FGF2 and AVP in human brain:
(A) FGF2 immunoreactivity was found within human magnocellular
neurons and their processes (arrowheads). FGF2 immunostain was
observed within endothelium of cerebral vessels (arrows) and in
astrocytes and their processes (bar = 50 μm). (B) Note AVP
immunoreactivity within neuronal perikarya and processes
(arrowheads) of magnocellular neurons in the PVN of adult human
hypothalamus. Axons are clearly distinguishable because their
‘beaded’ structure (bar = 50 μm). (C) Composite-merged image of
FITC-stained anti-AVP and LRSC-stained anti-FGF2
immunoreactivities generated from 46 sequential 0.2 μm slices at
200X. Co-localization of FITC-labeled AVP and LRSC-labeled FGF2
immunoreactivities was confirmed by yellow fluorescence. Yellow
fluorescence occurs in varying degrees in nearly all magnocellular
neurons (arrowheads). Some red LRSC-stained structures lacking
yellow fluorescence are probably astrocytes with processes (arrow).
Figure 3 Co-localization of FGF2 and AVP in human
magnocellular neurons: (A) Single labeled LRSC-stained anti-FGF2
and (B) FITC-stained anti-AVP images generated from 25 and 26
sequential 0.1 μm slices at 1000X magnification, respectively. Note
differences in the relative distribution of reaction product within this
neuron of the human SON. FGF2 is concentrated in small granular
structures in the apical portion of the neuronal perikaryon (A). AVP,
in contrast, is more homogeneously distributed in neuronal
cytoplasm. (C) Composite-merged view of LRSC-labeled anti-FGF2
and FITC-labeled anti-AVP immunoreactivities generated from 51
sequential 0.1 μm slices at 1000X. Note the tendency for co-
localized yellow reaction products to be concentrated in the apical
portion of this neuronal cell body.
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was more evident after merging LRSC-labeled anti-
FGF2 and FITC-labeled anti-AVP immunoreactivities
(Fig. 3C). Co-localized yellow immunofluorescence was
concentrated apically in the neuronal cell body. In fre-
quent observations, the juxtaposed neuronal processes
appeared as small yellow dots on the surface of cere-
bral vessels (Fig. 3C, bottom).
High resolution localization of FGF2 immunoreactivity in
magnocellular neurons of human PVN
To delineate cytoplasmic distribution of FGF2 immuno-
fluorescence, we examined LRSC-labeled anti-FGF2
immunoreactivity within the perikaryon of a neuron
from human PVN at high resolution, using the full pixel
array from 40 sequential 0.2 μms l i c e s( F i g .4 ) .F G F 2
reaction product was concentrated in small granule-like
structures within apical cytoplasm. Staining was absent
inside the nucleus, although some staining appeared on
the nuclear surface.
Immunolocalization of immunoreactive FGF2 and AVP in
rat paraventricular nucleus
In untreated rats, AVP as well as FGF2 immunoloca-
lized in both the neurohypophysis and hypothalamus.
Fig. 5 depicts FGF2 and AVP immunoreactivity in the
normal neural lobe and hypothalamic nuclei. Although
the neural lobe, PVN and SON all contained both
peptides, there were significant regional differences in
immunoreactive FGF2 distribution. In the neural lobe,
FGF2 immunoreactivity mainly localized to pituicytes
and basement membranes whereas immunoreactive
AVP was mainly associated with Herring bodies and
axonal fibers. In rat PVN, the astrocytes and parvocel-
lular neurons contained FGF2 immunoreactivity. In the
rat SON, astrocytes and selected populations of mag-
nocellular neurons showed strong FGF2 immunostain-
ing; however, we did not determine if the same
neurons express FGF2 and AVP immunoreactivity
Astrocytes were identified based on the characteristic
nuclear immunostaining for FGF2 [14]. Neurons were
identified based on their typical large round nucleus
and central nucleolus. No staining was observed when
sections were incubated with the antibody in the pre-
s e n c eo ft h ea n t i g e n i cp e p t i d eo rt h ee l u a n tf r o mt h e
affinity column used to purify the antibody (not
shown).
Effects of chronic dehydration on the distribution and
expression level of FGF2 in rats
To investigate FGF2’s possible role in modulating water
balance, we studied the localization and extent of immu-
noreactive FGF2 distribution in the neurohypophysis of
normal and water-deprived rats. In control pituitary
glands, FGF2 immunoreactivity localized to the neuro-
hypophysis, pars distalis and pars intermedia. In neuro-
hypophysis, immunoreactive FGF2 was associated with
basement membranes, Herring bodies derived from
magnocellular neurons (Fig. 6A) and pituicytes (Fig. 6B).
It is interesting to note strong localization of FGF2 in
the nuclear compartment of pituicytes. In the case of
AVP, large number of positive Herring bodies was
observed throughout the lobe, while fewer Herring
bodies were intensely stained for FGF2. After 72 h of
water deprivation, characteristic morphological changes
were observed throughout the neural lobe. Extracellu-
larly, there was a significant increase in the vascular
basement membranes associated with the perivascular
space (Fig. 6C). This was accompanied by an altered
pattern of immunoreactive FGF2, i.e., the increased
basement membrane structures within the perivascular
space all stained for FGF2 (Fig. 6C, compared to Fig
6A). Scattered Herring bodies also displayed FGF2
immunoreactivity (Fig. 6D). Pituicytes displayed strong
nuclear staining of FGF2 (Fig. 6D), although there was
no significant increase in pituicyte cell numbers. Dis-
rupted water balance thus resulted in enhanced expres-
sion of FGF2 in several regions of rat neurohypophysis.
No staining was observed when sections were incubated
with the antibody in the presence of the antigenic pep-
tide or the eluant from the affinity column used to pur-
ify the antibody (not shown).
Figure 4 FGF2 in granular structures within neurons in the
human paraventricular nucleus (PVN): High resolution (2000X)
rendering of the distribution of LRSC-labeled anti-FGF2
immunoreactivity within the perikaryon of a neuron from human
PVN generated with the full pixel array of 40 sequential 0.2 μm
slices. The blue dots represent FGF2 immunoreactivity. The green
and yellow dots indicate progressively greater anti-FGF2 reaction
product density (green < yellow), which is most notable in the
apical portion of the neuronal cytoplasm.
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displayed marked changes in the pattern of FGF2 immu-
nostaining in animals dehydrated for 72 h. Following
water deprivation, the levels of FGF2 immunoreactivity
were augmented in the cytoplasm, apical membrane and
nuclei of virtually all epithelial cells (Fig. 7A) but
reduced in the extracellular matrix (Fig. 7B). This is in
contrast to choroid tissues in control rats, with ad libi-
tum water intake, in which epithelial cells showed low
levels of intracellular FGF2 (Fig. 7C) but greater reaction
product in basement membranes (Fig. 7D).
Immunoblotting was performed with hypothalamus,
kidney and heart tissue extracts to determine if FGF2
isoforms were altered in dehydrated rats. Following
water-deprivation for 3d, there was an increase (by wes-
tern blot analysis) in the levels of all forms of FGF2 (ca.
18, 23 and 24 kDa) in the rat hypothalamus (Fig. 8). In
contrast, in the kidney there was a clear reduction in
the levels of FGF2 after dehydration but no changes
were detected in the heart.
Discussion
A co-localization of immunoreactive FGF2, AVP and
their cognate receptors in the hypothalamus and chor-
oid plexus epithelium [17-19] supports an hypothe-
sized role [21] for integrating ion transport, membrane
Figure 5 Immunolocalization of FGF2 and AVP in hypothalamic and hypophyseal regions of adult rats: (A) In the neural lobe, FGF2 is
localized to basement membranes (arrowheads) and astrocytes (arrows), (B) whereas AVP is found in axonal fibers (stars) and Herring bodies
(arrowheads). (C) PVN astrocytes (arrows) and neurons (arrowheads) appear to contain FGF2. (D) It is not clear if the same neurons express both
FGF2 and AVP. (E) Most AVP-positive SON neurons (F) (arrowheads) are also stained for FGF2 (E). (Magnification bar = 100 μm)
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tissues, the peptide trio of AVP, angiotensin II (AII)
and atrial natriuretic peptide (ANP) maintain plasma
volume and osmolality while FGF2 has significant
hypotensive activity. By down-regulating CSF forma-
tion, the neuropeptides AVP, AII and ANP affect fluid
homeostasis within the brain [1,5,7,8,16,27]; these
same peptides also modulate fluid balance in periph-
eral tissues [28,29]. Both FGF2 and AII are linked to
AVP release from cells that regulate CSF formation
and blood flow in CNS. Accordingly, functional inter-
actions among AVP, AII and FGF2 occur in choroid
plexus, neuroendocrine regions and smooth muscle
cells. FGF2, TGF-beta and other growth factors [30]
help to regulate fluid balance by functionally coupling
with fluid-regulating peptides (e.g. AVP and AII) both
centrally and peripherally [31].
The study presented herein localized FGF2 in human
and rat PVN and SON neurons, and in neurohypophy-
sis. FGF2-like immunoreactivity was initially identified
in hypothalamo-hypophyseal tissue by Iwata and collea-
gues [22] who described numerous immunoreactive
Figure 6 Altered distribution of FGF2 in the rat neurohypophysis
after dehydration: In normal (A & B) and water-deprived rats (C & D),
tissues were immunostained with polyclonal antibodies against FGF2:
To visualize the changes in the localization of FGF2 in the extracellular
matrix, tissue sections were treated with antibody Ab773 (A & C). To
visualize the changes in intracellular FGF2, tissue sections were treated
with antibody Ab106 (B & D). In control animals, FGF2 is associated
with basement membranes (arrowheads), Herring bodies of axons of
neurosecretory neurons (stars) (A) and pituicytes (arrows). Notice the
characteristic beaded appearance of axons (B). In neurohypophyseal
tissue from experimental rats, (C) and (D) show that the characteristic
morphological changes associated with chronic dehydration are
accompanied by increased FGF2 staining in structures underlying
the perivascular space (arrowheads) (C). The hypertrophic pituicytes
(arrows) also display strong nuclear staining (D). (Magnification bar =
100 μm)
Figure 7 Altered distribution of FGF2 in choroid plexus of rat
brain after dehydration: FGF2 immunostaining in lateral ventricle
choroid plexus tissues was evaluated in adult rats exposed to chronic
water deprivation for 72 h. Anatomically, the choroidal villus consists
of a single layer of cuboidal epithelial cells that circumferentially
surrounds an inner vascular core and extracellular matrix. The apical
membrane faces the ‘outside’ CSF compartment; see Smith et al. [40]
for a delineated description of choroid structural features. Note the
marked FGF2 immunostaining in plexus parenchymal epithelium
from a dehydrated animal (A), particularly in the nuclei, cytoplasm
and the apical (CSF-facing) membrane, and the lower concentration
in basement membranes (B). Comparatively, normal animals show
lower levels of intracellular FGF2 in the epithelium (C), but stronger
staining associated with basement membranes (D). Tissues were
immunostained with polyclonal antibodies against FGF2: Ab106 (A &
C) and Ab773 (B & D).
Figure 8 Immunoblotting confirms enhanced hypothalamic
FGF2 expression after dehydration: FGF2 protein level was
analyzed by western blotting for control (C) and dehydrated (D)
states. Note the increased FGF2 levels in hypothalamus, resulting
from 3 days of water deprivation, for the 3 isoforms of about 18, 23
and 24 kDa. Heart, kidney and brain rat tissues were extracted as
described in the text and examined for rat FGF2 with a polyclonal
antibody recognizing 3 forms of endogenous FGF2. Equal amounts
of protein were loaded per well. Exposure time was 36 h.
Dehydration specifically elevated the expression of FGF2 in
hypothalamus but not in heart or kidney.
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extending lateroventrally and then caudally to the inter-
nal layer of median eminence. This pointed to a neu-
roendocrine-type pathway of FGF2 expression. In
addition, the neurohypophysis contained many FGF2-
like immunoreactive fibers. We extended Iwata’ss t u d i e s
and, with confocal microscopy, determined that FGF2
immunoreactivity in the PVN and SON of these neu-
roendocrine-like pathways co-localizes with AVP.
At a subcellular level, the differential distribution of
neuropeptides provides clues about function. By high-
resolution analysis of hypothalamic neurons, we found
that FGF2 immunostaining is associated with small
granular structures at the apical portion of the perikar-
yon. Immunoreactive AVP, in contrast, appeared to be
homogeneously distributed throughout neural cyto-
plasm. These localization patterns of immunoreactive
FGF2 and AVP most certainly reflect different modes of
peptidergic processing. Unlike AVP, the FGF2 peptide
lacks a leader sequence that enables Golgi-mediated
secretion. Thus, FGF2 is exported from the neuroendo-
c r i n ec e l lb yan o n - G o l g i - a s s ociated pathway [25,32]
with apparent linkage to the alpha subunit of Na
+-K
+
ATPase [23]. Many facets of AVP secretion are well
understood [33]. However, future work should ascertain
whether FGF2 is released at the apex of the perikaryon
or if it regulates the release and/or processing of the
AVP pro-hormone, as it does with luteinizing hormone-
releasing hormone [34]. It is interesting to note that
FGF2 and vasopressin immunoreactivities do not over-
lap within all neurons. Some neurons continue to
express only one peptide or the other. Since the physio-
logical mechanisms through which these two peptides
interact in regulating fluid balance remain unknown,
one can only speculate that the relative absence in some
neurons may have a physiological significance that is yet
to be determined.
In 1991, Frautschy et al. f i r s th y p o t h e s i z e dt h a tF G F 2
could be associated with water balance [21]. Since then,
numerous studies have intimated an FGF2 involvement
with hypophyseal-integrated water homeostasis
[19,23,24]. The results presented herein are novel in
describing that the hypothalamic-pituitary distribution
of immunoreactive FGF2 in humans resembles that of
AVP; and that dynamic changes in FGF2 expression
occur in PVN, SON and choroid plexus in response to
fluid dyshomeostasis. FGF2,a sA I I ,l i k e l yp r o m o t e st h e
release of cellular AVP, at least in choroid plexus; this
leads to reduced CSF formation rate. We propose that
the wide spectrum of actions of FGF2 in mitosis, angio-
genesis and cell growth can now be extended to include
a fluid-regulatory role [16,17].
To evaluate the putative role of FGF2 in water bal-
ance, we began by evaluating whether conditions that
change water dynamics consequently alter the distribu-
tion and level of FGF2. We found prominent tissue
remodeling and increased FGF2 immunoreactivity in the
pituitary neural lobe in rats subjected to 72 h of water
deprivation. Moreover chronic dehydration, salt loading
and hypernatremia also characteristically upregulate
AVP expression in the hypothalamic-pituitary axis [35]
and choroid plexus [36]. Interestingly, a similar FGF2-
AVP interaction has been previously noted during myo-
cardial remodeling [37]. These multiple, connected
observations lead us to think that the observed increase
in neurohypophysial FGF2 is linked to augmented
release of AVP from the pituitary during dehydration
and/or elevated plasma osmolality [38]. Pituitary FGF2
up-regulation after water deprivation provides strong
correlative evidence for a functional role of FGF2 in
fluid balance because AVP, which co-localizes with
FGF2 in the hypothalamic-pituitary axis and choroidal
epithelium, regulates ion and water fluxes in V2- and
V1-receptor-bearing targets such as kidney and choroid
plexus [8].
It is fascinating that 3 isoforms of hypothalamic FGF2
were augmented by the 3-day dehydration (Fig. 8). On
the other hand, enhanced expression of FGF2 in
response to dehydration was not observed in the non-
neural tissues compared: heart and kidney. Thus, in
brain but not in cardiac and renal tissues, there was
uniquely homeostatic-enhanced expression of all three
known molecular weight forms (18, 23 and 24 kDa) of
FGF2 (Fig. 8). These western blot data for FGF2 protein
are consistent with the increased FGF2 immunostaining
in SON and PVN (and choroidal epithelium) following
water deprivation. Cumulative evidence therefore indi-
cates that brain, which is responsible for regulating
AVP-sensitive fluid balance via central (choroid plexus)
and peripheral (kidney) organs, homeostatically modu-
lates its FGF2 and associated AVP levels in the face of
dehydration. It is interesting to note the decreased levels
of FGF2 in the kidney after chronic dehydration taking
into account that peripheral water homeostasis is regu-
lated by hypothalamic AVP. The data presented here
and the previous reports on the increased levels of FGF-
2 mRNA in the hypothalamus after fasting [39] suggest
that FGF2 may play a general role in regulating
hypothalamic function under different stress conditions.
Conclusions
Taken together, the analyses described herein for human
and rat CNS tissues, in conjunction with previous find-
ings localizing FGF2 and AVP peptides and their recep-
tors (involving structures associated with fluid
homeostatic functions), support the hypothesis that
FGF2 participates in water balance by modulating
responsive cells in the posterior pituitary and choroid
Gonzalez et al. Cerebrospinal Fluid Research 2010, 7:13
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Page 9 of 11plexus. In light of the dehydration response and the sub-
stantial increase of FGF2 in neuroendocrine-type cells
such as neurohypophyseal and choroid epithelial cells
that also contain AVP, the findings strengthen the work-
ing model that the endocrine control of fluid transport
and membrane permeability may involve locally-acting
paracrine factors such as FGF2 in the CNS. Whether
these apparent linkages among FGF2, AVP and water
balance exist in peripheral tissues is under investigation.
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